Pharmaceutical Sciences News

Mitochondrial dysfunction in vulnerable neurons in the brain can be an early indicator of Alzheimer’s disease, yet the underlying molecular mechanisms remain misunderstood.

Joseph Balthasar, BS '91 & PhD '96, David and Jane Chu Endowed Chair in Drug Discovery and Development and professor of pharmaceutical sciences, has received a new $1.8 million R01 grant from the National Cancer Institute (NCI) to develop an “inverse targeting” strategy to increase the safety and efficacy of anti-cancer antibody-drug conjugates.

The only pharmacy school-based program of its kind in the country, the MS in Clinical and Translational Therapeutics offers PharmD, undergraduate and health care professional students a unique opportunity to be involved in research and training to combat disease.

Robert M. Straubinger, PhD, has received a Fulbright Scholar Award, one of the most widely recognized and prestigious scholarships in the world.

BUFFALO, N.Y. -- A major limitation of treating breast cancer with a class of chemotherapeutic drugs known as anthracyclines is the development of cardiac damage in some patients.

C.K. “David” Chu, PhD ’75, received a 2021 State University of New York Honorary Doctorate of Science at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences commencement ceremony on May 15.